Cannara Biotech (TSX:LOVE) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 27, 2026)


TSX:LOVE Cannara Biotech Inc TSX:LOVE
92 GF Score
Price C$1.68
GF Value C$1.68
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Cannara Biotech Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Cannara Biotech's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

TSX:LOVE vs ZTS: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's Margin of Safety % (DCF FCF Based) falls into.


TSX:LOVE
92GF Score
Cannara Biotech Inc TSX:LOVE
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cannara Biotech (TSX:LOVE) Overvalued in 2026?

Based on GuruFocus' analysis, Cannara Biotech stock appears to be undervalued. The current stock price of C$1.68 is trading 0% below its estimated GF Value™ of C$1.68. GuruFocus considers Cannara Biotech to be Fairly Valued.

Key valuation signals for TSX:LOVE:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: C$1.68 vs. price of C$1.68 (0% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the TSX:LOVE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cannara Biotech Business Description

Other Exchanges LOVFF:USA8CB0:Germany
Address 1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .
92GF Score

Get the complete analysis for TSX:LOVE

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.68
Price
C$1.68
GF Value